Imaging-based differential diagnosis between multiple system atrophy and Parkinson's disease

Area of Science:

• Neurology
• Neuroimaging
• Differential Diagnosis

Background:

• Distinguishing between multiple system atrophy with predominant parkinsonian features (MSA-P) and Parkinson's disease (PD) is clinically significant.
• Several imaging and functional tests exist, including middle cerebellar peduncle (MCP) width, apparent diffusion coefficient (ADC) values, and MIBG scintigraphy.

Purpose of the Study:

• To directly compare the diagnostic utility of MCP width, putamen ADC, cerebellar ADC, and MIBG scintigraphy.
• To identify the optimal imaging biomarker for differentiating MSA-P from PD.

Main Methods:

• Retrospective analysis of 11 MSA-P and 36 PD patients.
• Measurement of MCP width, putamen ADC, and cerebellar ADC values.
• Assessment of (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy.
• Receiver operating characteristic (ROC) curve analysis to determine diagnostic accuracy (Area Under Curve - AUC).

Main Results:

• MCP width demonstrated the highest diagnostic accuracy (AUC=0.95) in background-matched patients.
• Putamen ADC values also showed high accuracy (AUC=0.88), outperforming cerebellar ADC (AUC=0.70) and MIBG scintigraphy (AUC=0.78).
• Similar performance trends were observed across all patient cohorts, irrespective of background matching.

Conclusions:

• Middle cerebellar peduncle width and putamen ADC values are superior imaging biomarkers for differentiating MSA-P from PD compared to cerebellar ADC and MIBG uptake.
• These findings support the use of MCP width and putamen ADC in the clinical diagnostic workup of parkinsonian syndromes.